14-day Premium Trial Subscription Try For FreeTry Free
$83.80
+0.470 (+0.564%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $80.50 $93.35 Thursday, 2nd May 2024 BMRN stock ended at $83.80. This is 0.564% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.43% from a day low at $81.43 to a day high of $85.04.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Dec 08, 2022 $103.99 $104.62 $103.17 $104.39 723 024
Dec 07, 2022 $101.09 $103.94 $101.09 $103.69 1 319 198
Dec 06, 2022 $102.97 $103.44 $101.17 $102.22 889 357
Dec 05, 2022 $105.00 $105.34 $103.25 $103.53 994 347
Dec 02, 2022 $103.00 $106.72 $102.75 $105.56 2 220 168
Dec 01, 2022 $100.71 $103.06 $99.29 $103.02 2 013 886
Nov 30, 2022 $98.51 $101.28 $97.85 $100.98 2 493 125
Nov 29, 2022 $99.01 $99.56 $97.00 $97.12 1 304 257
Nov 28, 2022 $97.25 $100.30 $96.52 $98.66 2 591 319
Nov 25, 2022 $97.46 $98.43 $96.31 $96.92 727 779
Nov 23, 2022 $95.09 $99.74 $94.91 $97.79 4 635 440
Nov 22, 2022 $88.99 $91.63 $88.01 $91.18 1 620 250
Nov 21, 2022 $88.67 $88.86 $87.98 $88.51 734 460
Nov 18, 2022 $88.04 $88.76 $87.65 $88.13 501 999
Nov 17, 2022 $85.66 $87.92 $85.63 $87.11 639 146
Nov 16, 2022 $86.69 $86.69 $85.51 $86.23 613 362
Nov 15, 2022 $85.30 $87.44 $84.78 $86.60 855 042
Nov 14, 2022 $84.96 $86.29 $83.75 $85.30 1 657 191
Nov 11, 2022 $82.69 $83.48 $80.57 $82.10 820 636
Nov 10, 2022 $82.95 $84.15 $82.49 $83.31 812 633
Nov 09, 2022 $81.08 $81.70 $80.53 $80.82 826 690
Nov 08, 2022 $81.50 $82.27 $80.62 $81.25 1 469 214
Nov 07, 2022 $82.46 $82.68 $80.66 $81.33 1 697 604
Nov 04, 2022 $84.79 $84.88 $81.54 $82.49 1 611 317
Nov 03, 2022 $84.59 $85.60 $83.75 $84.88 1 082 371
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT